Chronic Obstructive Pulmonary Disease (COPD) Drugs

Spiriva, Atrovent, and other COPD drugs have been linked to an increase risk of heart attack, stroke, and cardiovascular death.  A paper published in the Journal of the American Medical Association states that people taking Spiriva or Atrovent have a 58% increased of cardiac death, heart attack, or stroke.

The makers of Spiriva deny that their drug causes an increased risk of heart attack, stroke, or cardiac death.  The U.S. Food and Drug Administration have issued an early communication warning of a possible increased risk of stroke for people taking Spiriva.

If you or a loved one has suffered an adverse cardiac event, heart attack, stroke, or cardiac death while taking Spiriva®, Atrovent®, or any prescription drug for the treatment of COPD, The Law Offices of Larry H. Parker wants to help.  Larry H. Parker and his team of pharmaceutical litigation attorneys form a talented legal practice with the resources and experience to give you and your loved ones peace of mind.  Larry's team of attorneys has recovered 1 billion dollars for our clients.  To schedule a FREE, confidential, no obligation consultation, contact us via email using our case submission form or by phone at (800) 333-0000.  At Larry H. Parker, our clients have no upfront costs, charges or fees.  The Law Offices of Larry H. Parker accepts product liability cases throughout the United States, offices in Long Beach, Los Angeles, Riverside, and Fresno, California and Phoenix and Tucson, Arizona.  Tough times call for tough lawyers.  At Larry H. Parker, we'll fight for you!

Spiriva® and Atrovent® are registered trademarks of Boehringer Ingelheim Pharma GmbH & Co.